[1]王浩扬,韩 悦,谢金平,等.国家药品集中采购接续政策与医保支付标准的衔接研究[J].卫生经济研究,2024,41(09):62-65.
 WANG Haoyang,HAN Yue,XIE Jinping,et al.Study on the Connection between the Continuation Policy of National Centralized Drug Procurement and the Payment Standard of Medical Insurance[J].Journal Press of Health Economics Research,2024,41(09):62-65.
点击复制

国家药品集中采购接续政策与医保支付标准的衔接研究
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
41
期数:
2024年09期
页码:
62-65
栏目:
药械管理
出版日期:
2024-08-29

文章信息/Info

Title:
Study on the Connection between the Continuation Policy of National Centralized Drug Procurement and the Payment Standard of Medical Insurance
作者:
王浩扬1韩 悦1谢金平12邵 蓉12
1.中国药科大学监管科学研究院,江苏 南京 211198
2.中国药科大学药品监管创新与评价重点实验室,江苏 南京 211198
Author(s):
WANG Haoyang HAN Yue XIE Jinping SHAO Rong
Institute of Regulatory Science, China Pharmaceutical University, Nanjing Jiangsu 211198, China
关键词:
国家药品集中采购接续政策医保支付标准衔接机制
Keywords:
national centralized volume-based procurement of drugs continuation policy medical insurance payment standard cohesive mechanism
分类号:
R19
文献标志码:
A
摘要:
国家药品集中采购(集采)接续政策始终强调推动实施药品医保支付标准,做好集采药品中选价格与医保支付标准的协同。当前,集采药品的医保支付标准主要依靠集采推动价格形成,按通用名形成医保支付标准仍存在一定阻力。对此,应进一步厘清国家集采接续政策与医保支付标准之间的衔接关系,依据省际间中选品种价差、原研企业是否中选等因素,分级分类推进省级接续工作,科学制定医保支付标准,推动国家集采接续政策有效落地。
Abstract:
The continuation policy of national centralized drug procurement has always emphasized the promotion of the implementation of drug payment standard of medical insurance, and the synergy between the selected price of centralized procurement drugs and the payment standard of medical insurance. At present, the medical insurance payment standard of centralized procurement drugs mainly relies on the centralized procurement to promote the formation of the price, and there is still some resistance to the formation of the medical insurance payment standard according to the generic name of the drugs. In this regard, it is necessary to further clarify the cohesive relationship between the continuation policy of national centralized drug procurement and the payment standard of medical insurance. Based on factors such as inter provincial price differences of selected drugs and whether the original research enterprise has been selected, the continuation work at provincial level should be promoted in a graded and classified manner. The payment standard of medical insurance should be scientifically formulated in order to promote the effective implementation of the continuation policy of national centralized drug procurement.

参考文献/References:

[1] 聂浩淼,陈怡娜,张珂,等.典型国家或地区药品医保支付标准制定方法的国际经验及启示[J].上海医药,2024,45(01):60-64.
[2] 李孜,刘宇刚,陈偲演,等.德国参考定价制度对我国非独家药品医保支付标准的启示[J].中国医疗保险,2023(03):48-52.
[3] 常峰,崔鹏磊,夏强,等.德国药品参考价格体系对构建我国医保支付标准的启示[J].中国卫生政策研究,2015,8(07):55-60.
[4] 王琳宁,路云.日本“价格带”汇总的医保支付标准调整方式及启示[J].中国医疗保险,2023(02):12-18.

更新日期/Last Update: 2024-08-29